Bids Are Invited For Record Acquisition And Supply Of Medicines

First: That The Dr. Alfonso Asenjo Neurosurgery Institute Belongs To The Network Of Public Health Establishments And That Since 2010 It Has Held The Status Of Self-Managed Network Establishment; Second: That The Institute Of Neurosurgery, A Specialized Public Health Establishment, Which Is Responsible For Contributing To The Treatment Of Highly Complex Neurosurgical Pathologies, Has The Need To Acquire The Supply Of: Methadone 10 Mg. & Fentanyl 0.1 Mg./2 Ml. & Fentanyl 0.5 Mg/10Ml Amp.; Ketamine 500 Mg/10 Ml Fco.; Lorazepam 4 Mg/Ml Amp.; Morphine 10 Mg/1Ml Amp.; Diazepam 10 Mg Amp.; Midazolam 15 Mg/3 Ml Amp.; Midazolam 5 Mg/1 Ml Amp.; Midazolam 50 Mg/10 Ml Amp.; Amikacin 100 Mg Amp.; Clindamycin 600 Mg. & Metronidazole 500 Mg. Fco.; Sodium Acetate 30% 10 Ml Amp.; Double Distilled Water 5 Ml Amp.; Atropine 1 Mg/Ml Amp.; Chlorphenamine 10Mg/1Ml Amp.; Chlorpromazine 25 Mg/2Ml Amp.; Sodium Chloride 09% Amp 20 Ml Amp.; Diclofenac 75 Mg Amp.; Dobutamine 250 Mg/5 Ml Amp.; Domperidone 10Mg/2Ml Amp.; Dopamine 200 Mg Amp.; Droperidol 5 Mg/2Ml Amp.; Ephedrine 6% 1 Ml Amp.; Flumazenil 0.5Mg/5Ml Amp.; Glucose 30% 20 Ml Amp.; Ketoprofen 100 Mg/2 Ml Amp.; Lanatocid C 0.4Mg Amp.; Lidocaine 2% Amp 5 Ml. & Magnesium Sulfate 25% Amp 5 Ml. & Metamizole 1 Grm/2Ml Amp.; Metoclopramide 10 Mg/2 Ml Amp.; Nitroglycerin 50 Mg/10 Ml Fco.; Papaverine Hydrochloride 80 Mg/2 Ml Amp.; Potassium Chloride 10% 10 Ml. & Propranolol 1 Mg/1Ml Amp.; Sodium Chloride 10% Amp 20 Ml. Amp. Plastic Amp.; Zinc Sulfate 0.88% 10 Ml. & Sterile Vaseline 5 Ml Amp.; Verapamil 5 Mg/2 Ml Amp.; Dexamethasone 4 Mg/1 Ml Amp.; Distilled Water 1000 Ml Rigid Flask S/Twist Off System; Sodium Bicarbonate 1/6 Molar X 500 Ml.; Sodium Bicarbonate 2/3 Molar 250 Ml.; Sodium Chloride 0.9% 100 Ml Viaflex; Glucose 5% 100 Ml Viaflex; Mannitol 15% 500 Ml Rigid Flask; Lactated Ringer 500 Ml Rigid Flask, For The Pharmacy Unit, According To The Requirement Contemplated In The Annual Purchasing Plan; Third: That According To What Was Mentioned In The Previous Paragraph, The Institute Of Neurosurgery Published The Tenders; Id 1058086-19-Lq22, For The Acquisition In The Supply Of Serums And Topical Solutions; Id 1058086-22-Lq22, For The Acquisition In The Supply Of Medicines; Id 1058086-24-Lq22, For The Acquisition In The Supply Of Narcotic Drugs And Tablets; Id 1058086-33-Lq22, For The Acquisition In The Supply Of Various Medications; Fourth: That By Virtue Of The Aforementioned And In Response To The Considerations Made By The Evaluation Commission, The Dr. Alfonso Asenjo Neurosurgery Institute Awarded These Medications To Laboratorio Sanderson S.A., Rut. 91,546,000-3; Fifth: That On September 21, The Company Fresenius Kabi Chile Communicates That The Public Health Institute Has Ordered The Temporary Suspension Of Manufacturing At The Laboratorio Sanderson S.A. Plant, Based On A New Outbreak Of “Burkholderia Contaminans (Bbc)” In Chilean Hospitals, Reporting, At The Same Time, That There Were No Indications That The Outbreak Was Related To The Plant And That The Entire Manufacturing Process Was Subject To Review By Internal And External Auditors; Sixth: That On September 28, The Institute Of Public Health Of Chile, Orders The Withdrawal From The Market Of All Current Batches Of Products Manufactured By The Pharmaceutical Production Laboratory Owned By Laboratorio Sanderson S.A. Before January 13, 2023, As Reported In “Market Recall Alert No. 49/2023” And Batches Manufactured After That Date, Will Be Kept In Quarantine As A Preventive Health Measure At The Points Of Use; Seventh: That On September 29, The Company Fresenius Kabi Chile Issues A New Statement In Relation To The Health Alert Indicated In The Previous Paragraph Limiting The Use Of Laboratorio Sanderson S.A. Products. Clarifying That All Medications Manufactured Before January 13, 2023 Were “Under Preventive Recall”; Eighth: That On October 2, The Company Fresenius Kabi Chile Issues An Explanatory Statement Informing That The Warehouses Of “Laboratorio Sanderson S.A.” They Are Not Authorized To Distribute The Existing Stock That Their Warehouses Have; Ninth: That Due To The Restriction That The Company Still Has On Distributing Products To The Different Hospitals, The Neurosurgery Institute Needs To Safeguard The Acquisition Of The Medications That Were Awarded To Laboratorios Sanderson S.A. In Order To Be Able To Duly Fulfill And Satisfy The Healthcare Demand That Has Been Legally Entrusted To The Establishment; Tenth: That It Is Necessary To Ensure The Transparency Of This Process And To Know The Supply Conditions Prevailing In The Market Under The Modality Of Public Bidding In The Public Purchasing And Contracting System Established In Law No. 19,886 And Its Regulations; Eleventh: That There Are No Framework Agreements Signed By The Public Procurement And Contracting Directorate For The Purpose Of These Bidding Rules; Twelfth: That The Bidding Process That Will Be Regulated By These Bases, According To The Budget Estimates, Will Not Exceed 5,000 Utm As An Approximate Expense Of The Proposal, With Taxes Included; Thirteenth: Because These Are Goods Or Services Of Simple And Objective Specification, The Circumstances Indicated In Article 25 Of Decree 250 Of The Ministry Of Finance That Establishes The Regulation Of Law No. 19,886 Exist, Therefore This Tender Will Be Published In The Portal Www.Mercadopublico.Cl For A Period Of 10 Consecutive Days; Fourteenth: That There Are Suppliers In The Market That Meet The Requirements And To Whom You Wish To Access;